Dogwood Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +379.1% | +9,862.9% | -49.9% | -46.9% | -50.2% | +2,164.1% | -4.4% | |
| – | +645.1% | +9,862.9% | -49.9% | -46.9% | -50.2% | +297.2% | -49.0% | |
| – | +930.4% | +9,530.5% | -53.0% | -49.8% | -52.8% | +347.6% | -56.1% | |
| – | +930.4% | +9,530.5% | -53.0% | -49.8% | -52.8% | +347.6% | -56.1% | |
| – | +135.0% | -58.7% | – | – | – | – | – | |
| – | – | – | – | – | – | – | +5.0% | |
| – | – | – | – | – | – | – | +5.0% | |
| – | +296.5% | -70.9% | -16.7% | -18.2% | -65.6% | +8,274.7% | -49.1% | |
| – | +22.2% | -5.5% | -16.7% | -18.2% | -65.6% | +785.9% | -3.7% | |
| – | – | – | – | – | – | – | +14.4% | |
| – | -75.7% | +941.5% | -4.1% | +62.0% | -80.5% | +1,000.7% | -38.2% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | -51.6% | -49.5% | -48.0% | +1,588.5% | +16.5% | |
| – | – | – | – | – | – | – | – | |
| – | +0.0% | +2.0% | +69.1% | +32.9% | +69.6% | +36.8% | +699.8% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.